Pipeline

Pipeline
Product Description

Polpharma Biologics has its own pipeline of biosimilars for out-licensing.
We are focused on advancing and expanding our product portfolio to increase patient access to these much-needed therapies and are open to partnering with other organizations to co-develop or commercialize our biosimilars.

Polpharma Biologics

  • PL
  • 2021
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
Biopharmaceutical company
Generics/Biosimilars Manufacturer
Primary activities
Biopharmaceutical

Polpharma Biologics

  • PL
  • 2021
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
Biopharmaceutical company
Generics/Biosimilars Manufacturer
Primary activities
Biopharmaceutical

Polpharma Biologics resources (2)